Literature DB >> 24179148

Psychosocial interventions for people with both severe mental illness and substance misuse.

Glenn E Hunt1, Nandi Siegfried, Kirsten Morley, Thiagarajan Sitharthan, Michelle Cleary.   

Abstract

Over 50% of people with a severe mental illness also use illicit drugs and/or alcohol at hazardous levels. This review is based on the findings of 32 randomized controlled trials which assessed the effectiveness of psychosocial interventions, offered either as one-off treatments or as an integrated or nonintegrated program, to reduce substance use by people with a severe mental illness. The findings showed that there was no consistent evidence to support any one psychosocial treatment over another. Differences across trials with regard to outcome measures, sample characteristics, type of mental illness and substance used, settings, levels of adherence to treatment guidelines, and standard care all made pooling results difficult. More quality trials are required that adhere to proper randomization methods; use clinically valuable, reliable, and validated measurement scales; and clearly report data, including retention in treatment, relapse, and abstinence rates. Future trials of this quality will allow a more thorough assessment of the efficacy of psychosocial interventions for reducing substance use in this challenging population.

Entities:  

Keywords:  Cochrane review; dual diagnosis; psychosocial interventions

Mesh:

Substances:

Year:  2013        PMID: 24179148      PMCID: PMC3885307          DOI: 10.1093/schbul/sbt160

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  1 in total

Review 1.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  Glenn E Hunt; Nandi Siegfried; Kirsten Morley; Thiagarajan Sitharthan; Michelle Cleary
Journal:  Cochrane Database Syst Rev       Date:  2013-10-03
  1 in total
  5 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness.

Authors:  Sean M Murphy; Michael G McDonell; Sterling McPherson; Debra Srebnik; Frank Angelo; John M Roll; Richard K Ries
Journal:  Drug Alcohol Depend       Date:  2015-05-14       Impact factor: 4.492

3.  Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis.

Authors:  Musa Sami; Amanda Worker; Marco Colizzi; Luciano Annibale; Debasis Das; Marlene Kelbrick; Savitha Eranti; Tracy Collier; Chidimma Onyejiaka; Aisling O'Neill; David Lythgoe; Philip McGuire; Steve C R Williams; Matthew J Kempton; Sagnik Bhattacharyya
Journal:  Transl Psychiatry       Date:  2020-04-21       Impact factor: 6.222

4.  Repetitive transcranial magnetic stimulation (rTMS) in alcohol dependence: study protocol of a randomized controlled clinical trial of efficacy and working mechanisms.

Authors:  Renée S Schluter; Ruth J van Holst; Anna E Goudriaan
Journal:  BMC Psychiatry       Date:  2018-06-04       Impact factor: 3.630

5.  The Effect of Intermittent Theta Burst Stimulation (iTBS) in Patients With Alcohol Use Disorder: Study Protocol for a Randomized Controlled Trial.

Authors:  Chenxin Yuan; Hang Su; Tianzhen Chen; Valerie Voon; Jiang Du
Journal:  Front Psychiatry       Date:  2020-03-10       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.